155 related articles for article (PubMed ID: 28249964)
1. Minimal extrathyroidal extension does not affect survival of well-differentiated thyroid cancer.
Al-Qurayshi Z; Shama MA; Randolph GW; Kandil E
Endocr Relat Cancer; 2017 May; 24(5):221-226. PubMed ID: 28249964
[TBL] [Abstract][Full Text] [Related]
2. Use of radioiodine after thyroid lobectomy in patients with differentiated thyroid cancer: does it change outcomes?
Kiernan CM; Parikh AA; Parks LL; Solórzano CC
J Am Coll Surg; 2015 Apr; 220(4):617-25. PubMed ID: 25667136
[TBL] [Abstract][Full Text] [Related]
3. Effect of Tumor Size and Minimal Extrathyroidal Extension in Patients with Differentiated Thyroid Cancer.
Tam S; Amit M; Boonsripitayanon M; Busaidy NL; Cabanillas ME; Waguespack SG; Gross ND; Grubbs EG; Williams MD; Lai SY; Sturgis EM; Zafereo ME
Thyroid; 2018 Aug; 28(8):982-990. PubMed ID: 29936892
[TBL] [Abstract][Full Text] [Related]
4. Management and outcome of recurrent well-differentiated thyroid carcinoma.
Palme CE; Waseem Z; Raza SN; Eski S; Walfish P; Freeman JL
Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):819-24. PubMed ID: 15262757
[TBL] [Abstract][Full Text] [Related]
5. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.
Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB
Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196
[TBL] [Abstract][Full Text] [Related]
6. Application of the new American Thyroid Association guidelines leads to a substantial rate of completion total thyroidectomy to enable adjuvant radioactive iodine.
Kluijfhout WP; Pasternak JD; Drake FT; Beninato T; Shen WT; Gosnell JE; Suh I; C L; Duh QY
Surgery; 2017 Jan; 161(1):127-133. PubMed ID: 27855968
[TBL] [Abstract][Full Text] [Related]
7. Differentiated thyroid cancer: clinical characteristics, treatment, and outcome in patients under 21 years of age who present with distant metastases. A report from the Surgical Discipline Committee of the Children's Cancer Group.
La Quaglia MP; Black T; Holcomb GW; Sklar C; Azizkhan RG; Haase GM; Newman KD
J Pediatr Surg; 2000 Jun; 35(6):955-9; discussion 960. PubMed ID: 10873043
[TBL] [Abstract][Full Text] [Related]
8. Differentiated thyroid cancer in a Swedish county--long-term results and quality of life.
Malterling RR; Andersson RE; Falkmer S; Falkmer U; Niléhn E; Järhult J
Acta Oncol; 2010 May; 49(4):454-9. PubMed ID: 20092427
[TBL] [Abstract][Full Text] [Related]
9. Minimal extrathyroid extension in papillary thyroid carcinoma does not result in increased rates of either cause-specific mortality or postoperative tumor recurrence.
Hay ID; Johnson TR; Thompson GB; Sebo TJ; Reinalda MS
Surgery; 2016 Jan; 159(1):11-9. PubMed ID: 26514317
[TBL] [Abstract][Full Text] [Related]
10. Implications of prognostic factors and risk groups in the management of differentiated thyroid cancer.
Shaha AR
Laryngoscope; 2004 Mar; 114(3):393-402. PubMed ID: 15091208
[TBL] [Abstract][Full Text] [Related]
11. Extrathyroidal Extension Is Associated with Compromised Survival in Patients with Thyroid Cancer.
Youngwirth LM; Adam MA; Scheri RP; Roman SA; Sosa JA
Thyroid; 2017 May; 27(5):626-631. PubMed ID: 27597378
[TBL] [Abstract][Full Text] [Related]
12. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
[TBL] [Abstract][Full Text] [Related]
13. Microscopic Positive Margins in Differentiated Thyroid Cancer Is Not an Independent Predictor of Local Failure.
Wang LY; Ghossein R; Palmer FL; Nixon IJ; Tuttle RM; Shaha AR; Shah JP; Patel SG; Ganly I
Thyroid; 2015 Sep; 25(9):993-8. PubMed ID: 26122000
[TBL] [Abstract][Full Text] [Related]
14. Operative management of locally advanced, differentiated thyroid cancer.
Wang LY; Nixon IJ; Patel SG; Palmer FL; Tuttle RM; Shaha A; Shah JP; Ganly I
Surgery; 2016 Sep; 160(3):738-46. PubMed ID: 27302105
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of adverse pathological features in 1 to 4 cm low-risk differentiated thyroid carcinoma.
Murthy SP; Balasubramanian D; Subramaniam N; Nair G; Babu MJC; Rathod PV; Thankappan K; Iyer S; Vijayan SN; Prasad C; Nair V
Head Neck; 2018 Jun; 40(6):1214-1218. PubMed ID: 29417654
[TBL] [Abstract][Full Text] [Related]
16. A Relook at the T Stage of Differentiated Thyroid Carcinoma with a Focus on Gross Extrathyroidal Extension.
Song E; Lee YM; Oh HS; Jeon MJ; Song DE; Kim TY; Kim WB; Shong YK; Sung TY; Kim WG
Thyroid; 2019 Feb; 29(2):202-208. PubMed ID: 30358515
[TBL] [Abstract][Full Text] [Related]
17. Invasive well-differentiated thyroid carcinoma: effect of treatment modalities on outcome.
Segal K; Shpitzer T; Hazan A; Bachar G; Marshak G; Popovtzer A
Otolaryngol Head Neck Surg; 2006 May; 134(5):819-22. PubMed ID: 16647541
[TBL] [Abstract][Full Text] [Related]
18. Differentiated thyroid carcinoma with distant metastases at presentation: prognostic factors and outcome.
Haq M; Harmer C
Clin Endocrinol (Oxf); 2005 Jul; 63(1):87-93. PubMed ID: 15963067
[TBL] [Abstract][Full Text] [Related]
19. Poorly differentiated thyroid carcinoma and poorly differentiated area in differentiated thyroid carcinoma: is there any difference?
Bichoo RA; Mishra A; Kumari N; Krishnani N; Chand G; Agarwal G; Agarwal A; Mishra SK
Langenbecks Arch Surg; 2019 Feb; 404(1):45-53. PubMed ID: 30673845
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors affecting neck lymph node recurrence and distant metastasis in papillary microcarcinoma of the thyroid: results of a study in 445 patients.
Mercante G; Frasoldati A; Pedroni C; Formisano D; Renna L; Piana S; Gardini G; Valcavi R; Barbieri V
Thyroid; 2009 Jul; 19(7):707-16. PubMed ID: 19348581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]